{"success":true,"data":{"pressRelease":{"id":"45675","rtpr_id":"nPn3lhFqna","ticker":"GRAL","exchange":"NASDAQ","all_tickers":["GRAL"],"title":"GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference","author":"PR Newswire","published_at":"2026-05-26T20:01:00.543Z","article_body":"GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference\n\nPR Newswire\n\nMENLO PARK, Calif., May 26, 2026\n\nMENLO PARK, Calif., May 26, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a\nhealthcare company whose mission is to detect cancer early when it can be\ncured, today announced that company management will present at the Goldman\nSachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9\nat 11:20 a.m. ET.\n\n(https://mma.prnewswire.com/media/2460831/Grail_Logo.html)\n\nLive and replay webcasts may be accessed in the investor relations section of\nGRAIL's website at investors.grail.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4696748-1&h=3408476672&u=http%3A%2F%2Finvestors.grail.com%2F&a=investors.grail.com)\n. The webcast will be archived and available for reply for at least 30 days\nafter the event.\n\nAbout GRAIL\nGRAIL is a healthcare company whose mission is to detect cancer early, when it\ncan be cured. GRAIL is focused on alleviating the global burden of cancer by\nusing the power of next-generation sequencing, population-scale clinical\nstudies, and state-of-the-art machine learning, software, and automation to\ndetect and identify multiple deadly cancer types in earlier stages. GRAIL's\ntargeted methylation-based platform can support the continuum of care for\nscreening and precision oncology, including multi-cancer early detection in\nsymptomatic patients, risk stratification, minimal residual disease detection,\nbiomarker subtyping, treatment and recurrence monitoring. GRAIL is\nheadquartered in Menlo Park, CA with locations in Washington, D.C., North\nCarolina, and the United Kingdom.\n\nFor more information, visit grail.com.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html\n(https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html)\n\nSOURCE GRAIL, Inc.\n\n\n\nCorporate Communications: Kristen Davis, Trish Rowland, pr@grail.com; Investor Relations: Alex Dobbin, Alexis Tosti, ir@grail.com\n\nPhoto: \nhttps://mma.prnewswire.com/media/2460831/Grail_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved.","article_body_html":"","raw_payload":{"data":{"id":"nPn3lhFqna","title":"GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference","author":"PR Newswire","ticker":"GRAL","created":"2026-05-26T20:01:00.543Z","tickers":["GRAL"],"exchange":"NASDAQ","article_body":"GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference\n\nPR Newswire\n\nMENLO PARK, Calif., May 26, 2026\n\nMENLO PARK, Calif., May 26, 2026 /PRNewswire/ -- GRAIL, Inc. (Nasdaq: GRAL), a\nhealthcare company whose mission is to detect cancer early when it can be\ncured, today announced that company management will present at the Goldman\nSachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9\nat 11:20 a.m. ET.\n\n(https://mma.prnewswire.com/media/2460831/Grail_Logo.html)\n\nLive and replay webcasts may be accessed in the investor relations section of\nGRAIL's website at investors.grail.com\n(https://edge.prnewswire.com/c/link/?t=0&l=en&o=4696748-1&h=3408476672&u=http%3A%2F%2Finvestors.grail.com%2F&a=investors.grail.com)\n. The webcast will be archived and available for reply for at least 30 days\nafter the event.\n\nAbout GRAIL\nGRAIL is a healthcare company whose mission is to detect cancer early, when it\ncan be cured. GRAIL is focused on alleviating the global burden of cancer by\nusing the power of next-generation sequencing, population-scale clinical\nstudies, and state-of-the-art machine learning, software, and automation to\ndetect and identify multiple deadly cancer types in earlier stages. GRAIL's\ntargeted methylation-based platform can support the continuum of care for\nscreening and precision oncology, including multi-cancer early detection in\nsymptomatic patients, risk stratification, minimal residual disease detection,\nbiomarker subtyping, treatment and recurrence monitoring. GRAIL is\nheadquartered in Menlo Park, CA with locations in Washington, D.C., North\nCarolina, and the United Kingdom.\n\nFor more information, visit grail.com.\n\nView original content to download\nmultimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html\n(https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html)\n\nSOURCE GRAIL, Inc.\n\n\n\nCorporate Communications: Kristen Davis, Trish Rowland, pr@grail.com; Investor Relations: Alex Dobbin, Alexis Tosti, ir@grail.com\n\nPhoto: \nhttps://mma.prnewswire.com/media/2460831/Grail_Logo.jpg\n\nCopyright (c) 2026 PR Newswire Association,LLC. All Rights Reserved."},"type":"article","timestamp":"2026-05-26T20:01:00.578352957Z","server_sent_at_ms":1779825660578},"received_at":"2026-05-26T20:01:00.673Z","source_url":"https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html"},"analysis":{"id":"35107","press_release_id":"45675","analysis_json":{"industry":{"label":"Biotechnology","sector":"Health Care"},"redFlags":[],"eventType":"other","narrative":"GRAIL announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference.\n\nThe presentation is scheduled for Tuesday, June 9, at 11:20 a.m. ET in Miami, FL.\n\nLive and replay webcasts will be available on GRAIL's investor relations website for at least 30 days following the event.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Routine conference appearance -- no new data or guidance expected."},"keyFigures":{},"quotedText":"GRAIL, Inc. (Nasdaq: GRAL), a healthcare company whose mission is to detect cancer early when it can be cured, today announced that company management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9 at 11:20 a.m. ET.","namedEntities":{"people":[{"name":"Kristen Davis","role":"Corporate Communications"},{"name":"Trish Rowland","role":"Corporate Communications"},{"name":"Alex Dobbin","role":"Investor Relations"},{"name":"Alexis Tosti","role":"Investor Relations"}],"products":[],"companies":[{"name":"GRAIL, Inc.","ticker":"GRAL"},{"name":"Goldman Sachs","relationship":"conference host"}],"dollarAmounts":[]},"materialImpact":{"score":1,"reasoning":"Routine conference presentation announcement. No new financial data, clinical results, or strategic developments disclosed. Standard investor relations activity."},"tickerRelevance":{"others":[{"ticker":"GS","relevance":"conference host"}],"primary":"GRAL"},"globalImportance":15,"audienceRelevance":25,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"mid-cap","eventGravity":"low","sectorWeight":"high","householdBrandBoost":"moderate","retailFavoriteBoost":"low"}},"event_type":"other","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"GRAIL announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference.\n\nThe presentation is scheduled for Tuesday, June 9, at 11:20 a.m. ET in Miami, FL.\n\nLive and replay webcasts will be available on GRAIL's investor relations website for at least 30 days following the event.","key_figures":{},"named_entities":{"people":[{"name":"Kristen Davis","role":"Corporate Communications"},{"name":"Trish Rowland","role":"Corporate Communications"},{"name":"Alex Dobbin","role":"Investor Relations"},{"name":"Alexis Tosti","role":"Investor Relations"}],"products":[],"companies":[{"name":"GRAIL, Inc.","ticker":"GRAL"},{"name":"Goldman Sachs","relationship":"conference host"}],"dollarAmounts":[]},"model_name":"qwen3_6_27b_awq","prompt_hash":"sha256:727b4b9429a443af","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-05-26T20:01:37.250Z","global_importance":15,"audience_relevance":25,"importance_components":{"tickerTier":"mid-cap","eventGravity":"low","sectorWeight":"high","householdBrandBoost":"moderate","retailFavoriteBoost":"low"}},"durationMs":18035,"modelName":"george-droid-qwen-72b"}}